Clinical Trial Update: Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC) [Phase 2]

View source ↗

Summary

Phase 2 study of Thermodox with radiofrequency ablation in metastatic colorectal cancer was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Liver Metastasis

Drugs mentioned

• ThermoDox (doxorubicin liposome)

Snippet

Sponsor: Imunon | Conditions: Colon Cancer Liver Metastasis | Phase 2 | Status: TERMINATED | Results posted: 2022-10-13